Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVX Chevron	$148.23 +0.2%	$140.97	$132.04 ▼ $168.96	$258.43B	0.83	8.27 million shs	5.17 million shs
JNJ Johnson & Johnson	$155.90 +0.2%	$153.65	$140.68 ▼ $169.99	$374.29B	0.41	8.05 million shs	3.48 million shs
PFE Pfizer	$25.45 +0.5%	$23.67	$20.92 ▼ $31.54	$143.95B	0.58	41.63 million shs	27.10 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVX Chevron	+0.21%	+2.65%	+6.22%	+3.58%	-5.44%
JNJ Johnson & Johnson	+0.20%	+2.40%	+0.94%	+1.88%	+7.06%
PFE Pfizer	+0.49%	+4.69%	+8.89%	+10.68%	-8.04%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVX Chevron	4.4933 of 5 stars	2.1	3.0	4.2	0.0	2.9	1.7	3.1
JNJ Johnson & Johnson	4.8514 of 5 stars	2.3	5.0	4.2	3.9	3.0	1.7	1.9
PFE Pfizer	4.9745 of 5 stars	3.2	3.0	4.2	4.3	2.8	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVX Chevron	2.26	Hold	$160.41	8.22% Upside
JNJ Johnson & Johnson	2.55	Moderate Buy	$170.88	9.61% Upside
PFE Pfizer	2.45	Hold	$28.55	12.20% Upside

Current Analyst Ratings Breakdown

Latest PFE, JNJ, and CVX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/2/2025	CVX Chevron	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$162.00 ➝ $164.00
6/26/2025	CVX Chevron	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$164.00 ➝ $165.00
6/5/2025	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00
5/21/2025	PFE Pfizer	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $33.00
5/19/2025	PFE Pfizer	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$27.00 ➝ $26.00
5/13/2025	CVX Chevron	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/13/2025	CVX Chevron	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$173.00 ➝ $162.00
5/13/2025	CVX Chevron	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$188.00 ➝ $186.00
5/13/2025	CVX Chevron	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$176.00 ➝ $158.00
5/13/2025	JNJ Johnson & Johnson	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVX Chevron	$202.79B	1.28	$19.82 per share	7.48	$85.22 per share	1.74
JNJ Johnson & Johnson	$88.82B	4.22	$13.15 per share	11.86	$29.69 per share	5.25
PFE Pfizer	$63.63B	2.27	$4.39 per share	5.80	$15.62 per share	1.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVX Chevron	$17.66B	$8.75	16.94	11.77	2.52	7.76%	10.73%	6.45%	8/1/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	17.34	14.08	2.35	24.42%	33.46%	13.30%	7/16/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.44	8.40	0.92	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest PFE, JNJ, and CVX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/1/2025	Q2 2025	CVX Chevron	$1.58	N/A	N/A	N/A	$44.59 billion	N/A
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.65	N/A	N/A	N/A	$22.85 billion	N/A
5/2/2025	Q1 2025	CVX Chevron	$2.15	$2.18	+$0.03	$2.00	$49.05 billion	$47.61 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVX Chevron	$6.84	4.61%	N/A	78.17%	38 Years
JNJ Johnson & Johnson	$5.20	3.34%	N/A	57.84%	64 Years
PFE Pfizer	$1.72	6.76%	N/A	124.64%	16 Years

Latest PFE, JNJ, and CVX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025
5/2/2025	CVX Chevron	quarterly	$1.71	5.02%	5/19/2025	5/19/2025	6/10/2025
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVX Chevron	0.17	1.08	0.82
JNJ Johnson & Johnson	0.49	1.26	1.03
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVX Chevron	72.42%
JNJ Johnson & Johnson	69.55%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
CVX Chevron	0.21%
JNJ Johnson & Johnson	0.16%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVX Chevron	45,298	1.75 billion	1.74 billion	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

PFE, JNJ, and CVX Headlines

Recent News About These Companies

Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook

2 hours ago | finance.yahoo.com

Stocks At All-Time Highs – Grab Your Gains and Buy These 7% Dividend Gems

July 3 at 4:33 PM | 247wallst.com

Pfizer’s New Pneumococcal Vaccine Study: A Potential Game Changer for Children’s Health

July 3 at 12:20 PM | tipranks.com

Pfizer’s ARV-471: A Promising New Hope for Advanced Breast Cancer

July 3 at 12:20 PM | tipranks.com

Pfizer: Options Activity Speaks Bullish

July 3 at 10:36 AM | seekingalpha.com

Pfizer: Options Activity Speaks Bullish

July 3 at 10:02 AM | seekingalpha.com

Pfizer Trades Above 50-Day Average for a Month: Time to Buy?

July 3 at 9:51 AM | zacks.com

D.A. Davidson & CO. Has $49.12 Million Stock Position in Pfizer Inc. (NYSE:PFE)

July 3 at 8:46 AM | marketbeat.com

Mutual Advisors LLC Buys 20,583 Shares of Pfizer Inc. (NYSE:PFE)

July 3 at 8:25 AM | marketbeat.com

Teacher Retirement System of Texas Buys 361,603 Shares of Pfizer Inc. (NYSE:PFE)

July 3 at 7:29 AM | marketbeat.com

First Horizon Advisors Inc. Has $20.91 Million Stock Position in Pfizer Inc. (NYSE:PFE)

July 3 at 7:08 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by WCM Investment Management LLC

July 3 at 5:38 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Bought by DAVENPORT & Co LLC

July 3 at 5:18 AM | marketbeat.com

Is Pfizer Stock a Yield Trap?

July 3 at 4:28 AM | fool.com

Pfizer (PFE) Outperforms Broader Market: What You Need to Know

July 2 at 6:46 PM | zacks.com

Huge Unusual Volume In Pfizer Put Options Signals Investors Bullish Outlook

July 2 at 3:48 PM | talkmarkets.com

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons

July 2 at 2:06 PM | benzinga.com

Republicans subpoena former Pfizer exec over timing of COVID vaccine clinical tests

July 2 at 1:25 PM | msn.com

Pfizer’s New Study on Mevrometostat and Enzalutamide: Potential Game-Changer in Prostate Cancer Treatment?

July 2 at 12:41 PM | tipranks.com

Pfizer’s Phase 3 RSV Vaccine Study: A Potential Game-Changer for Maternal and Infant Health

July 2 at 12:41 PM | tipranks.com

Kanawha Capital Management LLC Purchases 24,026 Shares of Pfizer Inc. (NYSE:PFE)

July 2 at 9:08 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFE, JNJ, and CVX Company Descriptions

Chevron NYSE:CVX

$148.22 +0.25 (+0.17%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$148.30 +0.08 (+0.05%)

As of 07/3/2025 04:59 PM Eastern

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

Johnson & Johnson NYSE:JNJ

$155.90 +0.34 (+0.22%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$155.75 -0.15 (-0.10%)

As of 07/3/2025 04:59 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer NYSE:PFE

$25.44 +0.13 (+0.49%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$25.42 -0.03 (-0.11%)

As of 07/3/2025 05:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time